INmune Bio
(NASDAQ:INMB)
$10.49
0.01[0.10%]
At close: May 9
$10.49
0[0.00%]
After Hours: 5:35PM EDT
Q1 2024 earnings were released today after the market close
Today's conference call ended over 6 hours ago Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

INmune Bio Stock (NASDAQ:INMB), Quotes and News Summary

INmune Bio Stock (NASDAQ: INMB) stock price, news, charts, stock research, profile.

Open$10.430
Close$10.770
Volume / Avg.107.133K / 113.919K
Day Range10.320 - 10.860
52 Wk Range6.500 - 14.740
Market Cap$207.293M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
46
Short Interest
11.14%
Days to Cover11.84

Recent News

Why Elevai Labs Stock Is Trading Higher
Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio, Inc. (NASDAQ:INMB).
Erica Kollmann
Sponsored
INmune Bio – Helping Your Own Cells Fight Cancer And Reverse Alzheimer's Disease
David Moss, CEO of INmune Bio (NASDAQ: INMB) was recently a guest on Benzinga’s All-Access.
Dow Jumps 250 Points; US Jobless Claims Increase Last Week
U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose, gaining, 0.75% to 4,148.69.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
INMB
RENB

FAQ

Q

How do I buy INmune Bio (INMB) stock?

A

You can purchase shares of INmune Bio (NASDAQ: INMB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are INmune Bio's (INMB) competitors?

A

Other companies in INmune Bio’s space includes: Renovaro (NASDAQ:RENB), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).

Q

What is the target price for INmune Bio (INMB) stock?

A

The latest price target for INmune Bio (NASDAQ: INMB) was reported by Baird on Thursday, June 1, 2023. The analyst firm set a price target for 16.00 expecting INMB to rise to within 12 months (a possible 52.53% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for INmune Bio (INMB)?

A

The stock price for INmune Bio (NASDAQ: INMB) is $10.49 last updated Today at May 9, 2024 at 5:35 PM EDT.

Q

Does INmune Bio (INMB) pay a dividend?

A

There are no upcoming dividends for INmune Bio.

Q

When is INmune Bio (NASDAQ:INMB) reporting earnings?

A

INmune Bio’s Q2 earnings are confirmed for Monday, August 5, 2024.

Q

Is INmune Bio (INMB) going to split?

A

There is no upcoming split for INmune Bio.

Q

What sector and industry does INmune Bio (INMB) operate in?

A

INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch